Search / 24297 results found

from
to
  • Updated

SILVER SPRING, Md., Nov. 14, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved Fetroja (cefiderocol), an antibacterial drug for treatment of patients 18 years of age or older with complicated urinary tract infections (cUTI), including kidney infections caused by susceptible Gram-negative microorganisms, who have limited or no alternative treatment options.